Operation Warp Speed Funds Potential Antibody Therapy for COVID-19
Regeneron Pharmaceuticals signed a $450 million deal with the United States via Operation Warp Speed—a program initiated by the federal government to speed up the development and implementation of vaccines and treatments for COVID-19—to…